Literature DB >> 25992861

Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity.

Kiyoshi Hirahara1, Atsushi Onodera2, Alejandro V Villarino3, Michael Bonelli3, Giuseppe Sciumè3, Arian Laurence3, Hong-Wei Sun4, Stephen R Brooks4, Golnaz Vahedi3, Han-Yu Shih3, Gustavo Gutierrez-Cruz5, Shigeru Iwata3, Ryo Suzuki6, Yohei Mikami3, Yoshitaka Okamoto7, Toshinori Nakayama8, Steven M Holland9, Christopher A Hunter10, Yuka Kanno11, John J O'Shea12.   

Abstract

Interleukin-6 (IL-6) and IL-27 signal through a shared receptor subunit and employ the same downstream STAT transcription proteins, but yet are ascribed unique and overlapping functions. To evaluate the specificity and redundancy for these cytokines, we quantified their global transcriptomic changes and determined the relative contributions of STAT1 and STAT3 using genetic models and chromatin immunoprecipitation-sequencing (ChIP-seq) approaches. We found an extensive overlap of the transcriptomes induced by IL-6 and IL-27 and few examples in which the cytokines acted in opposition. Using STAT-deficient cells and T cells from patients with gain-of-function STAT1 mutations, we demonstrated that STAT3 is responsible for the overall transcriptional output driven by both cytokines, whereas STAT1 is the principal driver of specificity. STAT1 cannot compensate in the absence of STAT3 and, in fact, much of STAT1 binding to chromatin is STAT3 dependent. Thus, STAT1 shapes the specific cytokine signature superimposed upon STAT3's action.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25992861     DOI: 10.1016/j.immuni.2015.04.014

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  61 in total

Review 1.  CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.

Authors:  Kiyoshi Hirahara; Toshinori Nakayama
Journal:  Int Immunol       Date:  2016-02-12       Impact factor: 4.823

2.  JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer.

Authors:  Chunwan Lu; Asif Talukder; Natasha M Savage; Nagendra Singh; Kebin Liu
Journal:  Oncoimmunology       Date:  2017-02-10       Impact factor: 8.110

3.  Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation.

Authors:  Ka Lung Cheung; Fan Zhang; Anbalagan Jaganathan; Rajal Sharma; Qiang Zhang; Tsuyoshi Konuma; Tong Shen; June-Yong Lee; Chunyan Ren; Chih-Hung Chen; Geming Lu; Matthew R Olson; Weijia Zhang; Mark H Kaplan; Dan R Littman; Martin J Walsh; Huabao Xiong; Lei Zeng; Ming-Ming Zhou
Journal:  Mol Cell       Date:  2017-03-03       Impact factor: 17.970

4.  Differential T Cell Cytokine Receptivity and Not Signal Quality Distinguishes IL-6 and IL-10 Signaling during Th17 Differentiation.

Authors:  Lindsay L Jones; Rajshekhar Alli; Bofeng Li; Terrence L Geiger
Journal:  J Immunol       Date:  2016-02-24       Impact factor: 5.422

5.  Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses.

Authors:  Stephan Wilmes; Polly-Anne Jeffrey; Jonathan Martinez-Fabregas; Maximillian Hafer; Paul K Fyfe; Elizabeth Pohler; Silvia Gaggero; Martín López-García; Grant Lythe; Charles Taylor; Thomas Guerrier; David Launay; Suman Mitra; Jacob Piehler; Carmen Molina-París; Ignacio Moraga
Journal:  Elife       Date:  2021-04-19       Impact factor: 8.140

6.  The Transcription Factor T-bet Limits Amplification of Type I IFN Transcriptome and Circuitry in T Helper 1 Cells.

Authors:  Shigeru Iwata; Yohei Mikami; Hong-Wei Sun; Stephen R Brooks; Dragana Jankovic; Kiyoshi Hirahara; Atsushi Onodera; Han-Yu Shih; Takeshi Kawabe; Kan Jiang; Toshinori Nakayama; Alan Sher; John J O'Shea; Fred P Davis; Yuka Kanno
Journal:  Immunity       Date:  2017-06-13       Impact factor: 31.745

7.  Rapid Enhancer Remodeling and Transcription Factor Repurposing Enable High Magnitude Gene Induction upon Acute Activation of NK Cells.

Authors:  Giuseppe Sciumè; Yohei Mikami; Dragana Jankovic; Hiroyuki Nagashima; Alejandro V Villarino; Tasha Morrison; Chen Yao; Sadie Signorella; Hong-Wei Sun; Stephen R Brooks; Difeng Fang; Vittorio Sartorelli; Shingo Nakayamada; Kiyoshi Hirahara; Beatrice Zitti; Fred P Davis; Yuka Kanno; John J O'Shea; Han-Yu Shih
Journal:  Immunity       Date:  2020-10-02       Impact factor: 31.745

8.  Developmental Acquisition of Regulomes Underlies Innate Lymphoid Cell Functionality.

Authors:  Han-Yu Shih; Giuseppe Sciumè; Yohei Mikami; Liying Guo; Hong-Wei Sun; Stephen R Brooks; Joseph F Urban; Fred P Davis; Yuka Kanno; John J O'Shea
Journal:  Cell       Date:  2016-05-05       Impact factor: 41.582

9.  Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression.

Authors:  Christian Hundhausen; Alena Roth; Elizabeth Whalen; Janice Chen; Anya Schneider; S Alice Long; Shan Wei; Rebecca Rawlings; MacKenzie Kinsman; Stephen P Evanko; Thomas N Wight; Carla J Greenbaum; Karen Cerosaletti; Jane H Buckner
Journal:  Sci Transl Med       Date:  2016-09-14       Impact factor: 17.956

Review 10.  IL-27-induced modulation of autoimmunity and its therapeutic potential.

Authors:  Rakeshchandra R Meka; Shivaprasad H Venkatesha; Steven Dudics; Bodhraj Acharya; Kamal D Moudgil
Journal:  Autoimmun Rev       Date:  2015-08-05       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.